Status | Study |
Recruiting |
Study Name: Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Condition: Childhood Brain Stem Neoplasm Childhood Lymphoma Date: 2016-05-23 Interventions: Drug: Entinostat Given PO |
Recruiting |
Study Name: Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children Condition: Childhood Brain Stem Neoplasm Date: 2016-01-31 Interventions: Drug: Nimotuzumab Nimotuzumab |
Recruiting |
Study Name: Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors Condition: Medulloblastoma Astrocytoma, Grade III Glioblastoma Date: 2015-12-27 Interventions: Drug: Mebendazole chewable mebendazole tablets that can also be crushed and mixed with food or drink to |
Completed |
Study Name: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors Condition: Teratoid Tumor, Atypical Choroid Plexus Neoplasms Anaplast Date: 2013-10-28 Interventions: Drug: azurin-derived cell-penetrating peptide p28 Given IV |
Completed |
Study Name: Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors Condition: Anaplastic Astrocytoma Anaplastic Ependymoma Astrocytoma, Date: 2013-04-17 Interventions: Drug: imetelstat sodium Given IV Other Names: |
Completed |
Study Name: Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas Condition: Pediatric High Risk Gliomas Date: 2012-03-29 Interventions: Drug: Combination of two marketed drugs (irinotecan and cisplatin) Irinotecan and Cisplatin will be admi |
Withdrawn |
Study Name: A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Condition: Brain Stem Neoplasms Glioma P Date: 2010-08-14 Interventions: Drug: IMC-A12 Drug: Temsirolimus |
Terminated |
Study Name: Phase I Rindopepimut After Conventional Radiation in Children w/ Diffuse Intrinsic Pontine Gliomas Condition: Brain Cancer Brain Stem Tumors Date: 2010-01-27 Interventions: Biological: Rindopepimut 250 or 500 mcg; intradermal injection |
Active, not recruiting |
Study Name: External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Condition: Brain Cancer Date: 2009-11-11 Interventions: Other: cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan |
Completed |
Study Name: O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors Condition: Brain and Central Nervous System Tumors Date: 2006-01-10 Interventions: Drug: O6-benzylguanine Dosing |